370 related articles for article (PubMed ID: 37502362)
21. Unveiling efferocytosis-related signatures through the integration of single-cell analysis and machine learning: a predictive framework for prognosis and immunotherapy response in hepatocellular carcinoma.
Liu T; Li C; Zhang J; Hu H; Li C
Front Immunol; 2023; 14():1237350. PubMed ID: 37575252
[TBL] [Abstract][Full Text] [Related]
22. Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma.
Chen Y; Tang L; Huang W; Abisola FH; Zhang Y; Zhang G; Yao L
Biol Direct; 2023 Feb; 18(1):4. PubMed ID: 36750831
[TBL] [Abstract][Full Text] [Related]
23. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
Front Surg; 2022; 9():836080. PubMed ID: 35392063
[TBL] [Abstract][Full Text] [Related]
24. Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning.
Wang Q; Sun N; Zhang M
Int J Gen Med; 2023; 16():1833-1844. PubMed ID: 37213475
[TBL] [Abstract][Full Text] [Related]
25. A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration.
Chi H; Jiang P; Xu K; Zhao Y; Song B; Peng G; He B; Liu X; Xia Z; Tian G
Front Genet; 2022; 13():984273. PubMed ID: 36092898
[No Abstract] [Full Text] [Related]
26. Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model.
Cao H; Huang P; Qiu J; Gong X; Cao H
Heliyon; 2024 Feb; 10(3):e24861. PubMed ID: 38317886
[TBL] [Abstract][Full Text] [Related]
27. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
28. The Comprehensive Analysis of m6A-Associated Anoikis Genes in Low-Grade Gliomas.
Zheng H; Zhao Y; Zhou H; Tang Y; Xie Z
Brain Sci; 2023 Sep; 13(9):. PubMed ID: 37759912
[TBL] [Abstract][Full Text] [Related]
29. STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment.
Pu Z; Liu J; Liu Z; Peng F; Zhu Y; Wang X; He J; Yi P; Hu X; Fan X; Chen J
Cancer Cell Int; 2022 Oct; 22(1):314. PubMed ID: 36224658
[TBL] [Abstract][Full Text] [Related]
30. A signature based on neutrophil extracellular trap-related genes for the assessment of prognosis, immunoinfiltration, mutation and therapeutic response in hepatocellular carcinoma.
Wang L; Wang Q; Li Y; Qi X; Fan X
J Gene Med; 2024 Jan; 26(1):e3588. PubMed ID: 37715643
[TBL] [Abstract][Full Text] [Related]
31. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis.
Huang C; Zhang C; Sheng J; Wang D; Zhao Y; Qian L; Xie L; Meng Z
Front Genet; 2021; 12():717319. PubMed ID: 34899826
[No Abstract] [Full Text] [Related]
33. Construction of a gene signature associated with anoikis to evaluate the prognosis and immune infiltration in patients with colorectal cancer.
Wen H; Ni X; Qian S; Abdul S; Lv H; Chen Y
Transl Cancer Res; 2024 Apr; 13(4):1904-1923. PubMed ID: 38737694
[TBL] [Abstract][Full Text] [Related]
34. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
Li R; Zhao W; Liang R; Jin C; Xiong H
Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
[No Abstract] [Full Text] [Related]
35. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
Li Y; Zeng X
Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728
[No Abstract] [Full Text] [Related]
36. Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma.
Xu D; Wang Y; Wu J; Zhang Y; Liu Z; Chen Y; Zheng J
Front Cell Dev Biol; 2021; 9():686664. PubMed ID: 34631695
[No Abstract] [Full Text] [Related]
37. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of Anoiki-Related Lncrna Signature Prediction Model for KIRC Prognosis.
Su Y; Yang J
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38305400
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
40. A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.
Chen J; Wang H; Zhou L; Liu Z; Chen H; Tan X
Cancer Med; 2022 Dec; 11(24):5079-5096. PubMed ID: 35560794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]